Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia coli lipopolysaccharide.

The purpose of this study was to determine whether soluble CD14 (sCD14) in milk was affected by stage of lactation, milk somatic cell count (SCC), presence of bacteria, or lipopolysaccharide (LPS)-induced inflammation. Milk samples from 100 lactating cows (396 functional quarters) were assayed for sCD14 in milk to determine effects of stage of lactation, SCC, and intramammary infection. The concentration of sCD14 was highest in transitional milk (0 to 4 d postpartum) and in milk with high SCC (> 750,000 cells/ml). Most of the infected quarters (> 80%) were infected by coagulase-negative staphylococci and yeast. No difference was found between noninfected and infected quarters. One quarter of six healthy lactating cows was challenged with 100 microg LPS in order to study the kinetics of sCD14 during an LPS-induced inflammation. Milk samples were collected at various intervals until 72 h after injection. Rectal temperature, milk tumor necrosis factor-alpha, and interleukin-8 increased immediately after challenge. The increase in sCD14 paralleled the increase in SCC, peaked at 12 h, and started to decline after 24 h. Serum leakage, as characterized by the level of bovine serum albumin in milk, peaked at 4 h and then gradually decreased. All parameters remained at basal levels in control quarters throughout the study. In vitro experiments indicated that neutrophils released sCD14 in response to LPS in a dose-dependent manner. The results indicate that the concentration of sCD14 was significantly increased in milk after LPS challenge. The increase was not likely due to serum leakage. Instead, infiltrated neutrophils might be the main source of increased sCD14 in milk during inflammation.

[1]  Edward C. Jaenicke,et al.  Microbiological Procedures for the Diagnosis of Bovine Udder Infection and Determination of Milk Quality , 2004 .

[2]  M. Paape,et al.  Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice. , 2003, Veterinary research.

[3]  M. Paape,et al.  Recombinant bovine soluble CD14 sensitizes the mammary gland to lipopolysaccharide. , 2002, Veterinary immunology and immunopathology.

[4]  C. Burvenich,et al.  Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis , 2002, Inflammation Research.

[5]  S. Akira,et al.  Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Martin Recognition of bacterial endotoxin in the lungs. , 2000, American journal of respiratory cell and molecular biology.

[7]  M. Affolter,et al.  Innate Recognition of Bacteria in Human Milk Is Mediated by a Milk-Derived Highly Expressed Pattern Recognition Receptor, Soluble Cd14 , 2000, The Journal of experimental medicine.

[8]  P. Ferrara,et al.  Cutting Edge: Human B Cell Function Is Regulated by Interaction with Soluble CD14: Opposite Effects on IgG1 and IgE Production1 , 2000, The Journal of Immunology.

[9]  K. Frei,et al.  The origin and function of soluble CD14 in experimental bacterial meningitis. , 1999, Journal of immunology.

[10]  T. van der Poll,et al.  Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. , 1998, The Journal of infectious diseases.

[11]  Fürll,et al.  Different efficacy of soluble CD14 treatment in high‐ and low‐dose LPS models , 1998, European journal of clinical investigation.

[12]  D. Rodeberg,et al.  Azurophilic granules of human neutrophils contain CD14 , 1997, Infection and immunity.

[13]  M. Paape,et al.  Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli , 1997, Infection and immunity.

[14]  G. Raghu,et al.  Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. , 1997, American journal of respiratory and critical care medicine.

[15]  W. Graninger,et al.  Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria , 1996, Clinical and experimental immunology.

[16]  M. Paape,et al.  Intramammary defense against infections induced by Escherichia coli in cows. , 1996, American journal of veterinary research.

[17]  C. Gonzalo,et al.  Relationship between somatic cell count and intramammary infection of the half udder in dairy ewes. , 1995, Journal of dairy science.

[18]  P. Detmers,et al.  Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase. , 1995, Journal of immunology.

[19]  J. Silver,et al.  Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). , 1995, Journal of immunology.

[20]  R. Jack,et al.  Both membrane‐bound and soluble forms of CD14 bind to Gram‐negative bacteria , 1995, European journal of immunology.

[21]  M. Wurfel,et al.  Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein , 1995, The Journal of experimental medicine.

[22]  J. Silver,et al.  Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood. , 1994, Journal of immunology.

[23]  W. Schoeppe,et al.  Elevated levels of soluble CD 14 in serum of patients with systemic lupus erythematosus , 1994, Clinical and experimental immunology.

[24]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.

[26]  S. Goyert,et al.  Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. , 1993, Journal of immunology.

[27]  M. Paape,et al.  The Relationship of Milk Somatic Cell Count to Milk Yields for Holstein Heifers After First Calving , 1993 .

[28]  D. Shuster,et al.  Cytokine production during endotoxin-induced mastitis in lactating dairy cows. , 1993, American journal of veterinary research.

[29]  J. Strominger,et al.  Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. , 1991, Journal of immunology.

[30]  S. Wright,et al.  Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14 , 1991, The Journal of experimental medicine.

[31]  N. Hogg,et al.  Colony‐stimulating factors and interferon‐gamma differentially affect cell surface molecules shared by monocytes and neutrophils , 1990, Clinical and experimental immunology.

[32]  T. Elsasser,et al.  Radioimmunoassay for bovine tumor necrosis factor: concentrations and circulating molecular forms in bovine plasma. , 1990, Journal of immunoassay.

[33]  P. Brandtzaeg,et al.  Brief Definitive Report the Complex Pattern of Cytokines in Serum from Patients with Meningococcal Septic Shock Association between Interleukin 6, Interleukin 1, and Fatal Outcome , 2022 .

[34]  S. Goyert,et al.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. , 1988, Journal of immunology.

[35]  J. Strominger,et al.  Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigen , 1986, European journal of immunology.

[36]  R. Graziano,et al.  Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. S. Lee,et al.  Identification, properties, and differential counts of cell populations using electron microscopy of dry cows secretions, colostrum and milk from normal cows , 1980, Journal of Dairy Research.

[38]  M. Paape,et al.  Leukocytes--second line of defense against invading mastitis pathogens. , 1979, Journal of dairy science.

[39]  M. Paape,et al.  Plasma Corticosteroid, Circulating Leukocyte and Milk Somatic Cell Responses to Escherichia coli Endotoxin-Induced Mastitis 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[40]  G. Carlson,et al.  Isolation of leukocytes from bovine peripheral blood. , 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.